EWTX
Edgewise Therapeutics Inc

595
Mkt Cap
$3.04B
Volume
511,103.00
52W High
$30.48
52W Low
$10.60
PE Ratio
-18.18
EWTX Fundamentals
Price
$28.78
Prev Close
$28.68
Open
$28.67
50D MA
$24.69
Beta
1.33
Avg. Volume
1.93M
EPS (Annual)
-$1.45
P/B
5.43
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Campbell & CO Investment Adviser LLC Lowers Holdings in Edgewise Therapeutics, Inc. $EWTX
Campbell & CO Investment Adviser LLC trimmed its stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 90.2% during the 3rd quarter, according to its most recent disclosure with the...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Edgewise Therapeutics (NASDAQ:EWTX) Director Sells $3,399,466.24 in Stock
Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) Director Badreddin Edris sold 115,471 shares of the business's stock in a transaction that occurred on Wednesday, January 21st. The shares...
MarketBeat·6d ago
News Placeholder
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Consensus Rating of "Moderate Buy" by Brokerages
Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the eleven analysts that are covering the stock, Marketbeat.com...
MarketBeat·9d ago
News Placeholder
Edgewise Therapeutics (NASDAQ:EWTX) Shares Down 6.4% - Time to Sell?
Edgewise Therapeutics (NASDAQ:EWTX) Shares Down 6.4% - Should You Sell...
MarketBeat·14d ago
News Placeholder
Edgewise Therapeutics (NASDAQ:EWTX) Shares Up 7% - Should You Buy?
Edgewise Therapeutics (NASDAQ:EWTX) Stock Price Up 7% - Here's Why...
MarketBeat·15d ago
News Placeholder
Edgewise Therapeutics Provides Corporate Updates and Highlights Priorities for 2026
Edgewise Therapeutics Provides Corporate Updates and Highlights Priorities for 2026 Edgewise Therapeutics Provides Corporate Updates and Highlights Priorities for 2026 PR Newswire BOULDER, Colo...
PR Newswire·16d ago
News Placeholder
Edgewise Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026
Edgewise Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026 Edgewise Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on...
PR Newswire·23d ago
News Placeholder
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules PR Newswire BOULDER...
PR Newswire·24d ago
News Placeholder
Edgewise Therapeutics (NASDAQ:EWTX) Shares Gap Down - Here's What Happened
Edgewise Therapeutics (NASDAQ:EWTX) Shares Gap Down - What's Next...
MarketBeat·1mo ago
News Placeholder
This Biotech Fund Exited an $8 Million Edgewise Stake as the Stock Slid Double Digits
Key PointsCalifornia-based Foresite Capital Management VI sold 585,000 shares of Edgewise Therapeutics in the third quarter...
Nasdaq News: Markets·1mo ago
<
1
2
...
>

Latest EWTX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.